Lijun Mu

ORCID: 0000-0002-0012-9504
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immunotherapy and Immune Responses
  • MicroRNA in disease regulation
  • Cancer-related molecular mechanisms research
  • RNA Interference and Gene Delivery
  • Circular RNAs in diseases
  • Prostate Cancer Treatment and Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Extracellular vesicles in disease
  • Urinary Bladder and Prostate Research
  • Prostate Cancer Diagnosis and Treatment
  • Reconstructive Surgery and Microvascular Techniques
  • Chronic Myeloid Leukemia Treatments
  • Pelvic floor disorders treatments
  • Vascular Procedures and Complications
  • Peripheral Artery Disease Management
  • Immune Cell Function and Interaction
  • RNA Research and Splicing
  • Acute Myeloid Leukemia Research
  • Urologic and reproductive health conditions
  • vaccines and immunoinformatics approaches
  • RNA modifications and cancer
  • Ferroptosis and cancer prognosis
  • Telomeres, Telomerase, and Senescence

Dalian Medical University
2011-2024

Second Affiliated Hospital of Dalian Medical University
2011-2024

North Sichuan Medical University
2024

Affiliated Hospital of North Sichuan Medical College
2024

First Affiliated Hospital of Xi'an Jiaotong University
2015-2022

Xi'an Jiaotong University
2015-2020

University of Oslo
2004-2006

Norwegian Cancer Society
2005-2006

Oslo University Hospital
2004

A therapeutic strategy that targets multiple proinflammatory factors in inflammatory bowel disease (IBD) with minimal systemic side effects would be attractive. Here, we develop a drug-free, biodegradable nanomedicine acts against IBD by scavenging cell-free DNA (cfDNA) and reactive oxygen species (ROS). Polyethylenimine (PEI) was conjugated to antioxidative diselenide-bridged mesoporous organosilica nanoparticles (MONs) formulate (MON-PEI) exhibited high cfDNA binding affinity...

10.1126/sciadv.abj2372 article EN cc-by-nc Science Advances 2022-01-28

Inflammatory bowel disease (IBD) is characterized by chronic relapsing inflammation of the gastrointestinal tract. Oxidative stress plays a pivotal role in pathogenesis IBD. Selenium-containing amino acids reportedly have anti-oxidative and anti-inflammatory properties, but it remains unknown if selenium-containing can be used to treat This study aimed investigate effects two - selenocysteine selenocystine on oxidative mouse model dextran sulfate sodium (DSS)-induced IBD.C57BL/6 mice were...

10.2147/jir.s288412 article EN cc-by-nc Journal of Inflammation Research 2021-01-01

Here, we present results from a clinical trial employing new vaccination method using dendritic cells (DCs) transfected with mRNA allogeneic prostate cancer cell lines (DU145, LNCaP and PC-3). In all, 20 patients were enrolled 19 have completed vaccination. Each patient received at least four weekly injections 2 × 107 DCs either intranodally or intradermally. Safety feasibility of determined. Immune responses measured as delayed-type hypersensitivity by in vitro immunoassays including...

10.1038/sj.bjc.6602761 article EN cc-by-nc-sa British Journal of Cancer 2005-08-30

MicroRNAs, a kind of small non-coding RNAs, can regulate gene expression by targeting mRNAs for translational repression or degradation. Much evidence has suggested that miR-218 was tumor suppressor in many human cancers including prostate cancer. However, the underlying role angiogenesis and mechanisms PCa other remains to be unclear. Here this present study, we demonstrated inhibited cells vitro vivo. RICTOR, mTOR component 2, direct target miR218-RICTOR-VEGFA axis mechanism inhibiting...

10.18632/oncotarget.14131 article EN Oncotarget 2016-12-24

Abstract Tumor cells dying after cytotoxic therapy are a potential source of antigen for T-cell priming. Antigen-presenting (APC) can cross-present MHC I–restricted peptides the uptake cells. Depending on nature surrounding environmental signals, APCs then orchestrate spectrum responses ranging from immune activation to inhibition. Previously, we had demonstrated that combining radiation with either agonistic monoclonal antibody (mAb) CD40 or systemically administered TLR7 agonist could...

10.1158/2326-6066.cir-15-0253 article EN Cancer Immunology Research 2016-05-31

Abstract With the aim of producing large quantities mRNA‐transfected monocyte‐derived dendritic cells (DCs) to be used as cancer vaccines, a new clinical grade procedure has been developed. Peripheral blood mononuclear (PBMCs) obtained by leukapheresis were enriched for monocytes immunomagnetic depletion CD19 + B and CD2 T employing ISOLEX 300i device. After 5 days culture in gas permeable Teflon bags, using serum‐free medium supplemented with granulocyte/macrophage‐colony stimulating factor...

10.1046/j.1365-3083.2003.01333.x article EN Scandinavian Journal of Immunology 2003-11-01

Prostate cancer remains one of the most common and deadliest forms cancer, generally respond well to radical prostatectomy associated interventions, up 30% individuals will suffer disease relapse. Although BUB1B was found be essential for cell growth proliferation, even in several kinds tumor cells, specific importance mechanistic role prostate remain unclear.Quantitative Real-Time PCR Western-blot were used detection mRNA protein expression. Lentivirus infection overexpression or knock down...

10.2174/1871520620666200101141934 article EN Anti-Cancer Agents in Medicinal Chemistry 2020-01-02

Altered expression of microRNA (miRNA) is associated with the occurrence and metastasis various tumors. We previously found that miR-218 inhibits tumor angiogenesis through RICTOR/VEGFA axis in prostate cancer (PCa). In this study, we determined also had a negative effect on cell growth, migration, invasion ability PCa. Our data showed bound to Grb2-associated binding protein 2 (GAB2) 3'-UTR region inhibited GAB2 expression. As novel downstream target miR-218, has been reported be involved...

10.1016/j.yexcr.2020.112128 article EN cc-by-nc-nd Experimental Cell Research 2020-06-06

MicroRNA (miRNA) is a class of non‑coding single‑stranded RNA, able to regulate tumor‑associated genes via binding the 3'‑UTR target gene mRNA. Previous publications have demonstrated that miRNA‑218 (miR‑218) acts as tumor‑suppressive miRNA in various types human cancer, including prostate cancer (PCa). However, role miR‑218 regulating PCa cell stemness and epithelial‑mesenchymal transition remains unknown requires further research. In present study, it was downregulated 2 lines could...

10.3892/ol.2018.8877 article EN Oncology Letters 2018-06-01

BACKGROUND:The aim of this study was to compare the clinical safety and effectiveness transurethral bipolar plasmakinetic enucleation prostate (PKEP) vs. resection (PKRP) in treatment benign hyperplasia (BPH) more than 80 ml. MATERIAL AND METHODS:From June 2015 February 2019, 179 BPH patients with volume greater ml were enrolled separated into a PKEP (n=81) group PKRP (n=98). The 2 groups followed up for 6 months. We collected analyzed data from international Prostate Symptom Score (IPSS),...

10.12659/msm.921272 article EN Medical Science Monitor 2020-04-27

Enriched CD34(+) peripheral blood progenitor cells (PBPC) are frequently used as stem cell support in cancer patients following high dose therapy. Since precursor dendritic (DCs) originate from haematopoietic cells, purified might also serve starting for ex- vivo production of DC. In the present study we developed a clinical grade procedure DC derived enriched cells. Different concentrations were grown gas-permeable Teflon bags with different serum-free and serum-containing media...

10.1177/039463200401700305 article EN International Journal of Immunopathology and Pharmacology 2004-09-01

The aim of this study was to explore the value prostate-specific antigen (PSA) levels, ratio free PSA total (fPSA/TPSA), density (PSAD), digital rectal examination (DRE), transrectal prostate ultrasound (TRUS), and multiparameter MRI (MP-MRI) in differential diagnosis benign prostatic hyperplasia (BPH) cancer (PCa).From February 2016 September 2019, data from 620 patients who underwent systematic ultrasound-guided biopsy (STURS-PB) our hospital were retrospectively collected, including...

10.2147/cmar.s257769 article EN cc-by-nc Cancer Management and Research 2020-08-01

Renal cell carcinoma (RCC) is one of the most common malignant cancers in adult urinary system worldwide. Tumor angiogenesis a critical process during cancer progression, as it modulates carcinogenesis and metastasis. In recent years, microRNA‑218 (miR‑218) has been confirmed to play crucial role tumor suppression. However, miR‑218 RCC remains unclear. present study, was found that expression decreased tissues lines detected by real‑time PCR analysis. Tube formation assays migration also...

10.3892/or.2020.7759 article EN cc-by-nc-nd Oncology Reports 2020-09-08

The aim of this study was to assess the immunogenic potential irradiated lymphoma cells in vivo and determine whether immunogenicity can be enhanced by modulation host immune system. Syngeneic murine models ex were used as an orthotopic cellular vaccination prior challenge with viable tumor cells. We demonstrate that are poorly protective anti-tumor CD8 T-cell responses require addition immunostimulatory monoclonal antibody adjuvant, increased frequency antigen exposure multiple...

10.3109/10428194.2013.769219 article EN Leukemia & lymphoma/Leukemia and lymphoma 2013-01-23

Background: Colorectal cancer (CRC) is one of the leading causes cancer-related death, and up to 50% individuals will suffer relapse. Although transmembrane immunoglobulin domain-containing protein 1 (TMIGD1) was found be a protective factor in several renal intestinal diseases, specific role TMIGD1 CRC remains unclear. Objective: To determine tumor suppressor expression its function inhibiting CRC. Methods: We analyzed three Gene Expression Omnibus (GEO) datasets through GEO2R online tool...

10.1089/gtmb.2021.0169 article EN Genetic Testing and Molecular Biomarkers 2022-04-01

Background: Prostate cancer is one of the most commonly diagnosed cancers and common causes cancer-related deaths among men worldwide. Patients who are with localized prostate treated radical prostatectomy often respond well to therapy. The current standard therapy for involves maximal surgical resection, followed by radiotherapy chemotherapy. Clarifying molecular mechanism tumor proliferation recurrence becomes more important clinical therapies cancer. Methods: Quantitative Real-Time PCR...

10.2174/1871520620666200731161810 article EN Anti-Cancer Agents in Medicinal Chemistry 2020-07-31

The development of prostate cancer is complicated and involves a number tumor-associated gene expression level abnormalities. Gene chip technology high-throughput method that can detect levels in different tissues cells on large scale. In the present study, was used to screen differentially expressed genes PC-3 human following GRB-associated binding protein 2 (GAB2) knockdown, corresponding biological information analyzed investigate role GAB2 cancer. cell knocked out hybridization...

10.3892/ol.2020.11960 article EN Oncology Letters 2020-08-07
Coming Soon ...